Ratings by Citizens (Donald Ellis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/14/2020 | Horizon Therapeutics | HZNP | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/31/2019 | Sol Gel Technologies Ltd. | SLGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/12/2019 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/24/2019 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/24/2019 | Aerie Pharma | AERI | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/7/2019 | Sorrento Therapeutics | SRNE | New Coverage | Market Outperform (N/A) |
2.32 (0.00) |
-100% | Details | |
| 9/6/2019 | Aclaris Therapeutis | ACRS | Downgrade | Market Perform (Market Outperform) |
0.92 (6.33) |
588.04% | Details | |
| 8/9/2019 | Aclaris Therapeutis | ACRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/2/2019 | Aerie Pharma | AERI | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/2/2019 | Aclaris Therapeutis | ACRS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/10/2019 | Aclaris Therapeutis | ACRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/14/2019 | PLx Pharma | PLXP | New Coverage | Market Outperform (N/A) |
5.19 (0.09) |
-98.27% | Details | |
| 3/11/2019 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/1/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/16/2018 | Aclaris Therapeutis | ACRS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/17/2018 | Revance Therapeutic | RVNC | Downgrade | Market Perform (Market Outperform) |
25.95 (3.65) |
-85.93% | Details |
